The Tolerability，Safety，PK/PD Study of rhTPO in the Patients With Liver Function Impairment
Status:
Recruiting
Trial end date:
2020-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the tolerability, safety, pharmacokinetics and
pharmacodynamics of recombinant human thrombopoietin in the patients with different degree of
liver function impairment according Child- Pugh class.